Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2009 Nov 20;28447:32370-83. doi: 10.1074/jbc.M109.029314.
Show Gene links
Show Anatomy links
Polypyrimidine tract binding protein prevents activity of an intronic regulatory element that promotes usage of a composite 3'-terminal exon.
Anquetil V
,
Le Sommer C
,
Méreau A
,
Hamon S
,
Lerivray H
,
Hardy S
.
???displayArticle.abstract???
Alternative splicing of 3'-terminal exons plays a critical role in gene expression by producing mRNA with distinct 3'-untranslated regions that regulate their fate and their expression. The Xenopus alpha-tropomyosin pre-mRNA possesses a composite internal/3'-terminal exon (exon 9A9') that is differentially processed depending on the embryonic tissue. Exon 9A9' is repressed in non-muscle tissue by the polypyrimidine tract binding protein, whereas it is selected as a 3'-terminal or internal exon in myotomal cells and adult striated muscles, respectively. We report here the identification of an intronic regulatory element, designated the upstream terminal exon enhancer (UTE), that is required for the specific usage of exon 9A9' as a 3'-terminal exon in the myotome. We demonstrate that polypyrimidine tract binding protein prevents the activity of UTE in non-muscle cells, whereas a subclass of serine/arginine rich (SR) proteins promotes the selection of exon 9A9' in a UTE-dependent way. Morpholino-targeted blocking of UTE in the embryo strongly reduced the inclusion of exon 9A9' as a 3'-terminal exon in the endogenous mRNA, demonstrating the function of UTE under physiological circumstances. This strategy allowed us to reveal a splicing pathway that generates a mRNA with no in frame stop codon and whose steady-state level is translation-dependent. This result suggests that a non-stop decay mechanism participates in the strict control of the 3'-end processing of the alpha-tropomyosin pre-mRNA.
Awasthi,
Association of polyadenylation cleavage factor I with U1 snRNP.
2003, Pubmed
Awasthi,
Association of polyadenylation cleavage factor I with U1 snRNP.
2003,
Pubmed
Bartel,
MicroRNAs: target recognition and regulatory functions.
2009,
Pubmed
Bruno,
Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements.
2004,
Pubmed
Cartegni,
ESEfinder: A web resource to identify exonic splicing enhancers.
2003,
Pubmed
Castelo-Branco,
Polypyrimidine tract binding protein modulates efficiency of polyadenylation.
2004,
Pubmed
Charlet-B,
Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing.
2002,
Pubmed
Edwalds-Gilbert,
Regulation of poly(A) site use during mouse B-cell development involves a change in the binding of a general polyadenylation factor in a B-cell stage-specific manner.
1995,
Pubmed
Edwalds-Gilbert,
Alternative poly(A) site selection in complex transcription units: means to an end?
1997,
Pubmed
Frischmeyer,
An mRNA surveillance mechanism that eliminates transcripts lacking termination codons.
2002,
Pubmed
Gawande,
Drosophila Sex-lethal protein mediates polyadenylation switching in the female germline.
2006,
Pubmed
Gromak,
Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein.
2003,
Pubmed
Hamon,
Polypyrimidine tract-binding protein is involved in vivo in repression of a composite internal/3' -terminal exon of the Xenopus alpha-tropomyosin Pre-mRNA.
2004,
Pubmed
,
Xenbase
Hardy,
Characterization of muscle and non muscle Xenopus laevis tropomyosin mRNAs transcribed from the same gene. Developmental and tissue-specific expression.
1991,
Pubmed
,
Xenbase
Hardy,
Two skeletal alpha-tropomyosin transcripts with distinct 3'UTR have different temporal and spatial patterns of expression in the striated muscle lineages of Xenopus laevis.
1999,
Pubmed
,
Xenbase
Hua,
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice.
2008,
Pubmed
Kohtz,
Protein-protein interactions and 5'-splice-site recognition in mammalian mRNA precursors.
1994,
Pubmed
Kyburz,
Direct interactions between subunits of CPSF and the U2 snRNP contribute to the coupling of pre-mRNA 3' end processing and splicing.
2006,
Pubmed
Le Sommer,
PTB regulates the processing of a 3'-terminal exon by repressing both splicing and polyadenylation.
2005,
Pubmed
,
Xenbase
Lees-Miller,
Three novel brain tropomyosin isoforms are expressed from the rat alpha-tropomyosin gene through the use of alternative promoters and alternative RNA processing.
1990,
Pubmed
Longman,
Multiple interactions between SRm160 and SR family proteins in enhancer-dependent splicing and development of C. elegans.
2001,
Pubmed
Lou,
Regulation of alternative polyadenylation by U1 snRNPs and SRp20.
1998,
Pubmed
Maciolek,
Serine/arginine-rich proteins contribute to negative regulator of splicing element-stimulated polyadenylation in rous sarcoma virus.
2007,
Pubmed
Makeyev,
The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.
2007,
Pubmed
McCracken,
SRm160 splicing coactivator promotes transcript 3'-end cleavage.
2002,
Pubmed
McGlincy,
Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense?
2008,
Pubmed
Millevoi,
An interaction between U2AF 65 and CF I(m) links the splicing and 3' end processing machineries.
2006,
Pubmed
Méreau,
Xenopus as a model to study alternative splicing in vivo.
2007,
Pubmed
,
Xenbase
Nesic,
Upstream introns influence the efficiency of final intron removal and RNA 3'-end formation.
1994,
Pubmed
Niwa,
Mutation of the AAUAAA polyadenylation signal depresses in vitro splicing of proximal but not distal introns.
1991,
Pubmed
Peterson,
The developmentally regulated shift from membrane to secreted mu mRNA production is accompanied by an increase in cleavage-polyadenylation efficiency but no measurable change in splicing efficiency.
1991,
Pubmed
Peterson,
Regulated immunoglobulin (Ig) RNA processing does not require specific cis-acting sequences: non-Ig RNA can be alternatively processed in B cells and plasma cells.
1994,
Pubmed
Peterson,
Multiple features contribute to the use of the immunoglobulin M secretion-specific poly(A) signal but are not required for developmental regulation.
2006,
Pubmed
Peterson,
Mechanisms controlling production of membrane and secreted immunoglobulin during B cell development.
2007,
Pubmed
Proudfoot,
Integrating mRNA processing with transcription.
2002,
Pubmed
Saulière,
The polypyrimidine tract binding protein (PTB) represses splicing of exon 6B from the beta-tropomyosin pre-mRNA by directly interfering with the binding of the U2AF65 subunit.
2006,
Pubmed
Sazani,
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing.
2003,
Pubmed
Screaton,
Identification and characterization of three members of the human SR family of pre-mRNA splicing factors.
1995,
Pubmed
Seipelt,
A nonimmunoglobulin transgene and the endogenous immunoglobulin mu gene are coordinately regulated by alternative RNA processing during B-cell maturation.
1998,
Pubmed
Sharma,
Polypyrimidine tract binding protein controls the transition from exon definition to an intron defined spliceosome.
2008,
Pubmed
Takagaki,
The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation.
1996,
Pubmed
Tian,
A large-scale analysis of mRNA polyadenylation of human and mouse genes.
2005,
Pubmed
Tian,
Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing.
2007,
Pubmed
Yan,
Computational analysis of 3'-ends of ESTs shows four classes of alternative polyadenylation in human, mouse, and rat.
2005,
Pubmed
van Hoof,
Exosome-mediated recognition and degradation of mRNAs lacking a termination codon.
2002,
Pubmed
